EKATERINE BACHILAVA: Open Payments
NPI 1841769288 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$362 in 14 payments from 8 companies in 2025. Trend: 2023 $109 · 2024 $172 · 2025 $362
Food & beverage: $362
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 4 | $99 |
| CSL Behring | 2 | $66 |
| Phathom Pharmaceuticals, Inc. | 2 | $46 |
| SHIELD THERAPEUTICS INC | 2 | $42 |
| Boston Scientific Corporation | 1 | $37 |
| Novo Nordisk Inc | 1 | $29 |
| ABBVIE INC. | 1 | $25 |
| ALK-Abello, Inc | 1 | $18 |
Products named: OPZELURA, Andembry, VOQUEZNA, ACCRUFER, WaveWriter Alpha Prime 16, Ozempic, QULIPTA, Odactra.
Industry payments across NY — which companies pay providers there.
